Azee 500mg (Azithromycin)

Azee 500mg (Azithromycin 500mg): Complete Medical Guide — Uses, Dosage, Side Effects & Precautions

Medically reviewed by Dr. Emily Brown, PharmD, PhD — Pharmaceutical Scientist & Drug Information Specialist. Content verified against current FDA-approved product monographs, DailyMed prescribing labels, and peer-reviewed pharmacological literature. 

Regulatory Note: Azee 500mg contains Azithromycin 500mg, manufactured by Cipla Ltd., India — one of the world’s largest generic pharmaceutical manufacturers. The originator branded product, Zithromax (Pfizer), received initial FDA approval in 1991. Azee 500mg is a generic formulation containing the identical active molecule. Azithromycin is a prescription-only macrolide antibacterial drug in the United States and most regulated markets. 

Azee 500mg is a prescription oral antibiotic tablet containing Azithromycin 500mg as its active ingredient, manufactured by Cipla Ltd., India. It belongs to the macrolide (azalide) class of antibacterial drugs and is FDA-approved for the treatment of mild to moderate bacterial infections caused by susceptible organisms, including respiratory tract infections, skin and soft tissue infections, and certain sexually transmitted infections. 

Azithromycin was one of the most commonly prescribed antibiotics in the United States between 2013–2015, with an average of 443 prescriptions per 1,000 insured patients — approximately 15 million prescriptions annually (ClinicalTrials.gov protocol documentation citing pharmacy claims data). Its popularity stems from its long tissue half-life, which allows short treatment courses (often 3–5 days) compared to many other antibiotics requiring 7–14 days of therapy. 

Critical safety note not found in either competitor document: In 2013, the FDA issued a Drug Safety Communication warning that Azithromycin may cause abnormal changes in the electrical activity of the heart that can lead to potentially fatal irregular heart rhythms. This warning followed a large retrospective study published in the New England Journal of Medicine (Ray et al., 2012) that found a higher rate of cardiovascular death among patients prescribed Azithromycin compared to those on amoxicillin or no antibiotic. This is discussed in detail in the Precautions section below. 

Important: Azee 500mg is not effective against viral infections such as the common cold or flu. Using antibiotics when not needed increases the risk of developing drug-resistant bacteria. Use only as prescribed by a licensed healthcare provider. 

 What is Azee 500mg? 

Azee 500mg is a brand-name generic formulation of Azithromycin 500mg, manufactured by Cipla Ltd., one of India’s largest and most internationally recognized pharmaceutical companies, supplying medications to over 80 countries. In the United States, the equivalent branded product is Zithromax (Pfizer), initially approved by the FDA in 1991. 

Azithromycin is chemically classified as an azalide — a subclass of the macrolide antibiotic family, structurally derived from erythromycin but modified to improve gastrointestinal tolerability, tissue penetration, and dosing convenience. It demonstrates greatly enhanced activity against gram-negative bacteria (including Enterobacteriaceae) compared to erythromycin, while retaining coverage against many gram-positive organisms, atypical bacteria, and some mycobacterial species, per the NIH StatPearls monograph. 

Azee is available in multiple strengths including 250mg, 500mg, and 1000mg tablets, allowing dosing flexibility based on infection type and severity. 

How Does Azee 500mg Work? 

Mechanism of Action 

Azithromycin works by inhibiting bacterial protein synthesis. Specifically, it binds to the 23S ribosomal RNA of the bacterial 50S ribosomal subunit, blocking the translocation step of protein synthesis and impeding the assembly of the 50S ribosomal subunit itself — as confirmed in the FDA-approved Zithromax prescribing label. This action prevents bacteria from producing the proteins essential for their growth, replication, and survival. 

Depending on the concentration achieved at the site of infection and the susceptibility of the target organism, Azithromycin can be bacteriostatic (inhibiting bacterial growth) or bactericidal (killing bacteria). Because it does not kill bacteria immediately in all cases, it relies partly on the host immune system to clear the remaining bacterial burden — which is why completing the full prescribed course is essential even after symptoms improve. 

Azithromycin demonstrates cross-resistance with erythromycin — bacteria resistant to erythromycin are typically also resistant to Azithromycin, an important consideration in areas with high macrolide resistance rates. 

Pharmacokinetics — Why Short Courses Work 

One of Azithromycin’s most distinctive pharmacological features is its exceptionally long tissue half-life — approximately 68 hours in tissue, compared to a plasma half-life of 2–4 hours after a single dose. This occurs because Azithromycin concentrates extensively within cells and tissues, particularly at infection sites, reaching levels many times higher than simultaneous plasma concentrations. 

This tissue accumulation explains why short courses (3–5 days) achieve therapeutic effect comparable to longer courses of other antibiotics (7–10 days) — the drug remains at therapeutic concentrations in infected tissue for up to 10 days after the last dose. Neither competitor document explains this pharmacokinetic basis for Azithromycin’s short-course dosing regimens. 

Uses and FDA-Approved Indications of Azee 500mg 

Azee 500mg is FDA-approved (via the reference product Zithromax) for the treatment of mild to moderate infections caused by susceptible bacterial strains: 

1. Respiratory Tract Infections 

• Acute bacterial exacerbations of chronic bronchitis due to Haemophilus influenzae, Moraxella catarrhalis, or Streptococcus pneumoniae 
• Acute bacterial sinusitis due to the same three organisms 
• Community-acquired pneumonia (CAP) due to Chlamydophila pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae, or Streptococcus pneumoniae — in patients appropriate for oral therapy. The FDA label specifically states Azithromycin should not be used in patients with pneumonia judged inappropriate for oral therapy due to moderate-to-severe illness or risk factors. 
• Pharyngitis/tonsillitis caused by Streptococcus pyogenes — as an alternative to first-line therapy (penicillin) in patients who cannot use first-line agents 

2. Skin and Soft Tissue Infections 

Uncomplicated skin and skin structure infections caused by susceptible organisms, typically dosed as 500mg on Day 1 followed by 250mg daily for 4 more days. 

3. Sexually Transmitted Infections 

• Uncomplicated genital chlamydia infections and non-gonococcal urethritis/cervicitis due to Chlamydia trachomatis: typically treated with a single 1000mg (1g) dose 
• Uncomplicated gonococcal urethritis and cervicitis due to Neisseria gonorrhoeae: historically treated with a single 2000mg dose, though current CDC guidelines increasingly favour combination therapy with ceftriaxone due to rising resistance concerns — always follow current local clinical guidance 

Off-Label and Emerging Uses 

A 2024 recruiting clinical trial (ClinicalTrials.gov NCT06618534, Emory University) is investigating a single 500mg dose of Azithromycin for eradicating nasopharyngeal carriage of Neisseria meningitidis — building on a 2020 susceptibility study that found 100% of 205 invasive N. meningitidis isolates were susceptible to Azithromycin according to CLSI breakpoints. 

A retrospective cohort study at Texas Health Harris Methodist Hospital (2022–2023, published in a peer-reviewed antimicrobial stewardship abstract) evaluated a pharmacist-driven protocol standardizing Azithromycin dosing to 500mg for 3 days for community-acquired pneumonia and COPD exacerbations — demonstrating real-world implementation of stewardship-optimized short-course dosing across 507 patients. 

What Azee 500mg is NOT approved for: Azithromycin is not FDA-approved for the treatment of COVID-19 or any viral infection. It should never be used for colds, flu, or other viral illnesses, as this practice contributes to antibiotic resistance without providing therapeutic benefit. 

 Dosage and Administration of Azee 500mg 

Dosage and treatment duration depend on the specific infection being treated. The following reflects FDA-approved dosing regimens from the Zithromax prescribing label and current clinical practice: 

 

Indication	FDA / Clinical Dosing Regimen
Community-acquired pneumonia (mild-moderate)	500 mg on Day 1, then 250 mg once daily Days 2–5
Acute bacterial sinusitis	500 mg once daily for 3 days
Acute bacterial exacerbation of chronic bronchitis	500 mg once daily for 3 days
Pharyngitis/tonsillitis (alternative to first-line)	500 mg on Day 1, then 250 mg once daily Days 2–5
Uncomplicated skin/skin structure infections	500 mg on Day 1, then 250 mg once daily Days 2–5
Uncomplicated genital chlamydia / non-gonococcal urethritis/cervicitis	Single 1000 mg (1 g) dose
Uncomplicated gonococcal urethritis/cervicitis	Single 2000 mg (2 g) dose (with ceftriaxone per current guidelines)
Meningococcal carriage eradication (off-label)	Single 500 mg dose
Hepatic impairment	Pharmacokinetics not established — use with caution

 

How to Take Azee 500mg 

• Swallow the tablet whole with a full glass of water. Do not crush or chew it 
• May be taken with or without food; taking with food (particularly after a light meal) may reduce the likelihood of stomach upset 
• If taking an antacid containing aluminium or magnesium, separate dosing by at least 2 hours — antacids reduce Azithromycin peak plasma concentration 
• Take at approximately the same time each day to maintain consistent drug levels 
• Complete the full prescribed course even if symptoms improve after 1–2 days. Stopping early increases the risk of treatment failure and antibiotic resistance 
• Do not share this medication with others or use leftover tablets for a different infection without medical guidance 

Missed Dose 

If a dose is missed, take it as soon as you remember. If it is almost time for the next scheduled dose, skip the missed dose and continue with your regular schedule. Do not take a double dose to make up for a missed one. 

Overdose 

Symptoms of Azithromycin overdose may include severe nausea, vomiting, diarrhoea, and in rare cases, hearing changes or abnormal heart rhythm given the QT-prolongation risk discussed below. If an overdose is suspected, contact your doctor or emergency services immediately. 

 Side Effects of Azee 500mg 

Most Azithromycin side effects reported in clinical trials were mild to moderate and reversible upon discontinuation of the drug, per the FDA Zithromax prescribing label. Approximately 0.7% of patients in 5-day multiple-dose clinical trials discontinued therapy due to side effects. 

Common Side Effects 

• Nausea 
• Diarrhoea or loose stools 
• Abdominal pain 
• Headache 
• Vomiting 

Less Common Side Effects 

• Dizziness 
• Skin rash or itching 
• Vaginal irritation or yeast infection 
• Altered sense of taste 

Serious Side Effects — Seek Immediate Medical Attention 

• Angioedema: Swelling of the face, lips, tongue, or throat — a potentially serious adverse reaction explicitly documented in the FDA prescribing label. 
• Cholestatic jaundice / liver problems: Yellowing of the skin or eyes, dark urine, severe abdominal pain, or persistent nausea — cholestatic jaundice is a specifically documented potentially serious adverse reaction in the FDA label. 
• Severe allergic reactions: Hives, difficulty breathing, or swelling — seek emergency care immediately. 
• Severe skin reactions: Severe rash, blistering, or peeling skin may indicate Stevens-Johnson syndrome or similar reactions — discontinue and seek care immediately. 
• Irregular or rapid heartbeat, fainting, or severe dizziness: Potential signs of QT prolongation and cardiac arrhythmia — see Precautions section below for detailed cardiovascular safety information. 
• Clostridioides difficile-associated diarrhoea: Severe, persistent, or bloody diarrhoea that may occur during or even up to 2 months after completing Azithromycin therapy, as antibiotic use can disrupt normal gut flora. 

Report serious adverse effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 

Drug Interactions 

Azithromycin has a comparatively favourable drug interaction profile relative to other macrolides (such as erythromycin or clarithromycin) because it has minimal effect on the CYP3A4 hepatic enzyme system. However, clinically significant interactions do exist, particularly regarding cardiac and P-glycoprotein-related effects: 

 

Drug / Substance	Clinical Action	Mechanism / Risk
Class IA antiarrhythmics (quinidine, procainamide)	Avoid combination	Additive QT prolongation risk
Class III antiarrhythmics (amiodarone, dofetilide, sotalol)	Avoid combination	Documented QT prolongation case reports with amiodarone
Antipsychotics (e.g., pimozide) and fexinidazole	Avoid — high-risk QT combination	Both prolong QT; combined risk of torsades de pointes
Warfarin	Monitor INR closely	Modest decrease in warfarin clearance; possible increased anticoagulant effect
P-gp substrates (colchicine, digoxin, vincristine, pazopanib)	Avoid or monitor closely	Azithromycin inhibits P-glycoprotein; raises substrate plasma levels
Statins (e.g., simvastatin)	Monitor for muscle symptoms	Case reports of rhabdomyolysis with macrolide-statin combination
Antacids (aluminium/magnesium-containing)	Space dosing by 2+ hours	Reduces azithromycin peak plasma concentration
Nelfinavir	Monitor for adverse effects	Increases azithromycin plasma exposure
Ergot derivatives	Avoid combination	Theoretical risk of ergotism via CYP/P-gp interaction

 

Key Interactions — Detail 

QT-Prolonging Antiarrhythmics: A documented case report (Samarendra et al., Pacing and Clinical Electrophysiology, 2001) described QT prolongation associated with the combination of Azithromycin and amiodarone. Co-administration with Class IA antiarrhythmics (quinidine, procainamide) or Class III antiarrhythmics (dofetilide, amiodarone, sotalol) should generally be avoided due to additive QT-prolongation risk. 

Warfarin: A published pharmacotherapy study (Shrader et al., 2004) documented an interaction between Azithromycin and warfarin. Evidence is somewhat conflicting, but the general finding is a modest decrease in warfarin clearance and a possible increase in anticoagulant effect. Patients on warfarin should have their INR monitored closely when starting or stopping Azee 500mg. 

Statins — Rhabdomyolysis Risk: A study published in the British Journal of Clinical Pharmacology (Strandell et al.) identified rhabdomyolysis as an “unrecognized interaction” between Azithromycin and statins. Patients on statin therapy should be monitored for unexplained muscle pain, tenderness, or weakness while taking Azee 500mg. 

P-glycoprotein (P-gp) Substrates: Azithromycin functions as a P-gp inhibitor, which can increase serum concentrations of P-gp substrate drugs including colchicine, digoxin, topotecan, rimegepant, pazopanib, and vincristine — increasing the risk of toxicity from these medications. 

Precautions and Warnings 

Cardiovascular Safety — QT Prolongation and Risk of Cardiovascular Death 

This is the single most important safety consideration for Azee 500mg that both competitor documents fail to adequately address. In March 2013, the FDA issued a Drug Safety Communication warning that Azithromycin “can cause abnormal changes in the electrical activity of the heart that may lead to a potentially fatal irregular heart rhythm.” This warning was based on a landmark retrospective study published in the New England Journal of Medicine (Ray et al., 2012), which analysed 347,795 Azithromycin prescriptions and found 29 cardiovascular deaths — a significantly higher rate than the 42 deaths among 1,348,672 amoxicillin prescriptions or the 41 deaths among 1,391,180 patients taking no antibiotic. 

The risk was found to be substantially higher in patients with pre-existing cardiovascular risk factors. Notably, the risk of cardiovascular death with a comparator drug, levofloxacin, was not significantly different from Azithromycin — indicating this is a class consideration relevant to several antibiotics, not unique to Azithromycin alone. 

In an updated safety review (Therapeutic Goods Administration, Australia, reflecting analysis through March 2024), regulators noted an approximately two-fold increased short-term risk of acute cardiovascular death in adults exposed to Azithromycin relative to other antibacterial drugs including amoxicillin. This risk was found to be greatest during the first 5 days of Azithromycin use. Regulators now advise that healthcare professionals consider a screening ECG in patients at high risk of prolonged QT before prescribing. 

Patients at elevated risk of QT-related complications include those with: 

• Known prolongation of the QT interval or congenital long QT syndrome 
• History of torsades de pointes 
• Bradyarrhythmias or uncompensated heart failure 
• Uncorrected hypokalaemia or hypomagnesaemia (low potassium or magnesium) 
• Concurrent use of other QT-prolonging medications 
• Advanced age — elderly patients may be more susceptible to drug-associated QT effects 

If you experience lightheadedness, heart palpitations, fainting, or blurred vision while taking Azee 500mg, report these symptoms to your prescriber immediately, and seek emergency care if severe. 

Liver Disease 

Azee 500mg should not be used in patients with a history of jaundice or hepatic dysfunction associated with prior Azithromycin or erythromycin use. Cholestatic jaundice is a documented, potentially serious adverse reaction. The pharmacokinetics of Azithromycin in hepatic impairment have not been formally established — it should be prescribed cautiously in patients with liver disease, per NIH StatPearls. 

Kidney Disease 

Patients with significant kidney impairment should be evaluated by their healthcare provider, as drug clearance may be affected. Dose adjustment may be necessary based on clinical judgement. 

Myasthenia Gravis 

Macrolide antibiotics including Azithromycin have been associated with exacerbation of myasthenia gravis symptoms, including new-onset muscle weakness. Patients with this condition should discuss the risks with their healthcare provider before starting Azee 500mg. 

Clostridioides difficile-Associated Diarrhoea (CDAD) 

Like nearly all antibacterial agents, Azithromycin use can lead to CDAD, ranging from mild diarrhoea to fatal colitis, by disrupting normal gut flora and allowing C. difficile overgrowth. This can occur over two months after the completion of antibacterial treatment. If diarrhoea develops during or after treatment, contact your healthcare provider. 

Pregnancy and Breastfeeding 

Pregnant and breastfeeding women should consult their healthcare provider before using Azee 500mg. For azithromycin eye drops specifically, StatPearls notes the risk to breastfeeding infants is negligible, and pressure over the tear duct for 1 minute post-administration further reduces transfer to breast milk — though this pertains to ophthalmic use, not oral tablets. For oral Azee 500mg, discuss the risk-benefit profile with your doctor. 

Sun Sensitivity 

Azithromycin may increase sensitivity to sunlight. Avoid prolonged direct sun exposure and tanning beds during treatment, and use sunscreen if outdoor exposure is unavoidable. 

Antibiotic Resistance — Responsible Use 

The FDA label explicitly states: “Prescribing Azithromycin in the absence of a proven or strongly suspected bacterial infection is unlikely to provide benefit to the patient and increases the risk of the development of drug-resistant bacteria.” Azee 500mg should only be used for confirmed or strongly suspected bacterial infections — never for viral illnesses. 

Azee 500mg vs. Zithromax — Generic vs. Brand Comparison 

Both Azee 500mg and Zithromax contain the identical active ingredient — Azithromycin 500mg — and share the same mechanism of action, FDA-referenced indications, and clinical efficacy profile. Key differences: 

• Manufacturer: Zithromax is manufactured by Pfizer (US, originally approved 1991); Azee is manufactured by Cipla Ltd. (India) 
• Regulatory pathway: Zithromax holds the original FDA New Drug Application; generic Azithromycin products are approved through the FDA’s Abbreviated New Drug Application (ANDA) process, requiring proven bioequivalence 
• Cost: Generic Azithromycin (including Azee) is substantially less expensive than branded Zithromax 
• Clinical equivalence: For the purposes of treating bacterial infections at approved doses, generic Azithromycin and Zithromax are considered therapeutically equivalent 

Storage Instructions 

• Store Azee 500mg at room temperature, in a dry, dark place away from direct sunlight and moisture 
• Keep tablets in their original packaging or blister strip until ready for use — do not remove tablets in advance 
• Ensure the blister strip remains intact; do not use tablets that appear damaged or discoloured 
• Store out of reach of children and pets at all times 
• Check the expiry date before use. Do not take expired medication 
• Dispose of unused or expired tablets through a medicine take-back programme rather than household waste 

Frequently Asked Questions (FAQs) 

What is the generic name for Azee 500mg? 

The generic name is Azithromycin. Azee 500mg is a brand name used by manufacturer Cipla Ltd. for this Azithromycin 500mg formulation. 

What is the US brand equivalent of Azee 500mg? 

The equivalent branded product available in the United States is Zithromax (manufactured by Pfizer), which contains the identical active ingredient, Azithromycin. 

What is Azee 500mg used for? 

Azee 500mg is used to treat bacterial infections including community-acquired pneumonia, acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, pharyngitis/tonsillitis (as an alternative to first-line therapy), uncomplicated skin infections, and certain sexually transmitted infections including chlamydia. It is not effective against viral infections. 

Can Azee 500mg cause heart problems? 

Yes — this is an important safety consideration. The FDA issued a Drug Safety Communication in 2013 warning that Azithromycin can cause QT interval prolongation, which may lead to a potentially fatal irregular heart rhythm. The risk is higher in patients with pre-existing heart conditions, electrolyte imbalances, or those taking other QT-prolonging medications. Report palpitations, dizziness, or fainting to your doctor immediately. 

Can I take antacids with Azee 500mg? 

Antacids containing aluminium or magnesium can reduce the peak plasma concentration of Azithromycin. If you need to take an antacid, separate the dosing from Azee 500mg by at least 2 hours to avoid reduced drug absorption. 

Do I need to complete the full course of Azee 500mg even if I feel better? 

Yes. Stopping antibiotic treatment early — even if symptoms improve within a day or two — can lead to incomplete eradication of the bacterial infection and contributes to the development of antibiotic-resistant bacteria. Always complete the full course as prescribed by your doctor. 

Is Azee 500mg the same as Zithromax? 

Yes, pharmacologically. Both contain Azithromycin 500mg as the active ingredient and are considered therapeutically equivalent. Zithromax is the FDA-approved branded originator (Pfizer); Azee is a generic manufactured by Cipla Ltd. The differences are manufacturer, regulatory pathway, and cost. 

What should I avoid while taking Azee 500mg? 

Avoid alcohol (may worsen gastrointestinal side effects), antacids without proper spacing, other antibiotics without medical guidance, and prolonged sun exposure without protection. Inform your doctor of all other medications, particularly warfarin, statins, and any antiarrhythmic drugs. 

 Medical Disclaimer 

All information in this guide is provided for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Azee 500mg is a prescription-only antibiotic and should only be used under the supervision of a licensed healthcare provider. Never self-medicate, share antibiotics with others, or use leftover antibiotics for a different illness. In an emergency, contact local emergency services immediately. Report suspected adverse effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.